Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://www.rdinvesting.com/ and get exclusive access to our numerous stock reports and market updates.
E I Du Pont De Nemours And Co. (NYSE: DD) shares gained 0.08 percent to close at $60.22 a share Wednesday. The stock traded between $59.90 and $60.55 on volume of 3.99 million shares traded. Analysts at JPMorgan have recently upgraded the company’s rating to "overweight" from "neutral". Shares of Du Pont have gained approximately 34.0 percent year-to-date.
Find out more about Du Pont including full access to the free equity report at:
www.RDInvesting.com/DD
Finish Line Inc. (NASDAQ: FINL) shares increased 1.61 percent to close at $25.21 a share Wednesday. The stock traded between $24.94 and $25.34 on volume of 571,152 shares traded. Analysts at Canaccord Genuity have recently upgraded the company’s rating to "buy" from "hold". Shares of Finish Line have gained approximately 33.0 percent year-to-date.
Find out more about Finish Line including full access to the free equity report at:
www.RDInvesting.com/FINL
Medtronic, Inc. (NYSE: MDT) shares increased 1.62 percent to close at $57.65 a share Wednesday. The stock traded between $56.90 and $57.88 on volume of 4.95 million shares traded. Analysts at Deutsche Bank have recently upgraded the company’s rating to "buy" from "hold". Shares of Medtronic have gained approximately 40.0 percent year-to-date.
Find out more about Medtronic including full access to the free equity report at:
www.RDInvesting.com/MDT
Syngenta AG (NYSE: SYT) shares increased 2.04 percent to close at $81.72 a share Wednesday. The stock traded between $81.71 and $82.27 on volume of 235,694 shares traded. Analysts at HSBC Securities have recently upgraded the company’s rating to "overweight" from "neutral". Shares of Syngenta have gained approximately 1.0 percent year-to-date.
Find out more about Syngenta including full access to the free equity report at:
www.RDInvesting.com/SYT
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.
Contact:
Research Driven Investing
info@rdinvesting.com